Breaking News: 4-Year Medtronic Low-Risk TAVR Clinical Trial Results

Learn new medical findings and insights from the Medtronic Evolut Low-Risk Clinical Trial in this special interview with Dr. Michael Reardon, Professor of Cardiovascular Surgery at Houston Methodist in Houston, Texas, and Co-Principal Investigator of the Medtronic Evolut Low-Risk TAVR Clinical Trial. (Video posted on May 28, 2024)